91 related articles for article (PubMed ID: 27984765)
1. HPV prevalence in women attending cervical screening in rural Malawi using the cartridge-based Xpert
Cubie HA; Morton D; Kawonga E; Mautanga M; Mwenitete I; Teakle N; Ngwira B; Walker H; Walker G; Kafwafwa S; Kabota B; Ter Haar R; Campbell C
J Clin Virol; 2017 Feb; 87():1-4. PubMed ID: 27984765
[TBL] [Abstract][Full Text] [Related]
2. Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening.
Učakar V; Poljak M; Oštrbenk A; Klavs I
J Med Virol; 2014 Oct; 86(10):1772-9. PubMed ID: 24978445
[TBL] [Abstract][Full Text] [Related]
3. Field Evaluation of Xpert HPV Point-of-Care Test for Detection of Human Papillomavirus Infection by Use of Self-Collected Vaginal and Clinician-Collected Cervical Specimens.
Toliman P; Badman SG; Gabuzzi J; Silim S; Forereme L; Kumbia A; Kombuk B; Kombati Z; Allan J; Munnull G; Ryan C; Vallely LM; Kelly-Hanku A; Wand H; Mola GDL; Guy R; Siba P; Kaldor JM; Tabrizi SN; Vallely AJ
J Clin Microbiol; 2016 Jul; 54(7):1734-1737. PubMed ID: 27076663
[TBL] [Abstract][Full Text] [Related]
4. Aptima HPV Assay versus Hybrid Capture
Cook DA; Smith LW; Law J; Mei W; van Niekerk DJ; Ceballos K; Gondara L; Franco EL; Coldman AJ; Ogilvie GS; Jang D; Chernesky M; Krajden M
J Clin Virol; 2017 Feb; 87():23-29. PubMed ID: 27988420
[TBL] [Abstract][Full Text] [Related]
5. Detection of human papillomavirus in fresh and dried urine through an automated system for cervical cancer screening in low- and middle-income countries.
Tanzi E; Bianchi S; Fappani C; Gori M; Colzani D; Passera I; Tincati C; Canuti M; Raviglione M; Amendola A
J Med Virol; 2023 May; 95(5):e28802. PubMed ID: 37219045
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of human papillomavirus in women attending cervical screening in the UK and Ireland: new data from northern Ireland and a systematic review and meta-analysis.
Anderson L; O'Rorke M; Jamison J; Wilson R; Gavin A;
J Med Virol; 2013 Feb; 85(2):295-308. PubMed ID: 23161367
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus prevalence in paired urine and cervical samples in women invited for cervical cancer screening.
Burroni E; Bonanni P; Sani C; Lastrucci V; Carozzi F; ; Iossa A; Andersson KL; Brandigi L; Di Pierro C; Confortini M; Levi M; Boccalini S; Indiani L; Sala A; Tanini T; Bechini A; Azzari C
J Med Virol; 2015 Mar; 87(3):508-15. PubMed ID: 25418873
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus detection and genotyping, by HC2, full-spectrum HPV and molecular beacon real-time HPV assay in an Irish colposcopy clinic.
Keegan H; Pilkington L; McInerney J; Jeney C; Benczik M; Cleary S; von Bunau G; Turner M; D'Arcy T; O' Toole S; Pal-Szenthe B; Kaltenecker B; Mózes J; Kovács A; Solt A; Bolger N; O'Leary J; Martin C
J Virol Methods; 2014 Jun; 201():93-100. PubMed ID: 24583109
[TBL] [Abstract][Full Text] [Related]
10. Population-based study for human papillomavirus (HPV) infection in young women in Japan: A multicenter study by the Japanese human papillomavirus disease education research survey group (J-HERS).
Sasagawa T; Maehama T; Ideta K; Irie T;
J Med Virol; 2016 Feb; 88(2):324-35. PubMed ID: 26147986
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and genotype distribution of human papillomavirus infection of the cervix in Spain: the CLEOPATRE study.
Castellsagué X; Iftner T; Roura E; Vidart JA; Kjaer SK; Bosch FX; Muñoz N; Palacios S; San Martin Rodriguez M; Serradell L; Torcel-Pagnon L; Cortes J;
J Med Virol; 2012 Jun; 84(6):947-56. PubMed ID: 22499018
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Xpert
Rabaan AA; Taylor DR; Dawamneh MF; Al-Tawfiq JA
J Infect Public Health; 2017; 10(2):219-223. PubMed ID: 27343005
[TBL] [Abstract][Full Text] [Related]
13. Stability Study of Cervical Specimens Collected by Swab and Stored Dry Followed by Human Papillomavirus DNA Detection Using the cobas 4800 Test.
Lin CQ; Zeng X; Cui JF; Liao GD; Wu ZN; Gao QQ; Zhang X; Yu XZ; Chen W; Xi MR; Qiao YL
J Clin Microbiol; 2017 Feb; 55(2):568-573. PubMed ID: 27927922
[TBL] [Abstract][Full Text] [Related]
14. High-risk HPV detection and genotyping by APTIMA HPV using cervical samples.
Pyne MT; Hamula CL; Tardif K; Law C; Schlaberg R
J Virol Methods; 2015 Sep; 221():95-9. PubMed ID: 25956671
[TBL] [Abstract][Full Text] [Related]
15. Genotyping and follow-up of HR-HPV types detected by self-sampling in women from low socioeconomic groups not participating in regular cervical cancer screening in France.
Tamalet C; Halfon P; Retraite LL; Grob A; Leandri FX; Heid P; Sancho-Garnier H; Piana L
J Clin Virol; 2016 May; 78():102-7. PubMed ID: 27015435
[TBL] [Abstract][Full Text] [Related]
16. Comparison of hybrid capture 2 High-Risk HPV results in the low positive range with cobas® HPV Test results from the ATHENA study.
Rao A; Sandri MT; Sideri M; Young S; Sharma A; Behrens C
J Clin Virol; 2013 Sep; 58(1):161-7. PubMed ID: 23895930
[TBL] [Abstract][Full Text] [Related]
17. Population-based evaluation of type-specific HPV prevalence among women in British Columbia, Canada.
Ogilvie GS; Cook DA; Taylor DL; Rank C; Kan L; Yu A; Mei W; van Niekerk DJ; Coldman AJ; Krajden M
Vaccine; 2013 Feb; 31(7):1129-33. PubMed ID: 23273510
[TBL] [Abstract][Full Text] [Related]
18. Cervical human papillomavirus among 19 753 women attending gynecological department of a major comprehensive hospital in north Anhui China 2013-2016: Implication for cervical cancer screening and prevention.
Liu H; Wei X; Xie Z; Wang X; Gong X; Ke W; Zou H
J Med Virol; 2019 Apr; 91(4):698-706. PubMed ID: 30475384
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the Anyplex II HPV28 assay with the Hybrid Capture 2 assay for the detection of HPV infection.
Kwon MJ; Roh KH; Park H; Woo HY
J Clin Virol; 2014 Apr; 59(4):246-9. PubMed ID: 24568964
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of genotype-specific HPV clearance and reinfection in rural Ghana may compromise HPV screening approaches.
Krings A; Boateng G; Dunyo P; Amuah JE; Adams RA; Adunyame L; Nkansah DO; Wormenor CM; Hansen BT; Gedzah I; Asmah RH; Wiredu EK; Kaufmann AM
Papillomavirus Res; 2019 Jun; 7():45-51. PubMed ID: 30625379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
